SG10201500719VA - Transformation plasmid - Google Patents

Transformation plasmid

Info

Publication number
SG10201500719VA
SG10201500719VA SG10201500719VA SG10201500719VA SG10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA
Authority
SG
Singapore
Prior art keywords
transformation plasmid
plasmid
transformation
Prior art date
Application number
SG10201500719VA
Inventor
Yuko Shimatani
Hitomi Shimizu
Takayuki Sasaki
Original Assignee
Anaeropharma Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaeropharma Science Inc filed Critical Anaeropharma Science Inc
Publication of SG10201500719VA publication Critical patent/SG10201500719VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SG10201500719VA 2010-01-29 2011-01-28 Transformation plasmid SG10201500719VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29992210P 2010-01-29 2010-01-29

Publications (1)

Publication Number Publication Date
SG10201500719VA true SG10201500719VA (en) 2015-03-30

Family

ID=44319445

Family Applications (3)

Application Number Title Priority Date Filing Date
SG2012050795A SG182445A1 (en) 2010-01-29 2011-01-28 Transformation plasmid
SG2012050803A SG182446A1 (en) 2010-01-29 2011-01-28 Transformation plasmid
SG10201500719VA SG10201500719VA (en) 2010-01-29 2011-01-28 Transformation plasmid

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG2012050795A SG182445A1 (en) 2010-01-29 2011-01-28 Transformation plasmid
SG2012050803A SG182446A1 (en) 2010-01-29 2011-01-28 Transformation plasmid

Country Status (8)

Country Link
US (3) US8535939B2 (en)
EP (4) EP2910636B1 (en)
JP (2) JP5836129B2 (en)
KR (2) KR20120112824A (en)
CN (2) CN102741407B (en)
CA (2) CA2787787A1 (en)
SG (3) SG182445A1 (en)
WO (3) WO2011093467A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9730968B2 (en) 2008-04-17 2017-08-15 Anaeropharma Science, Inc. Therapeutic agent for ischemic diseases
EP2910636B1 (en) 2010-01-29 2018-01-17 Anaeropharma Science, Inc. Transformation plasmid
KR20140046463A (en) 2011-07-13 2014-04-18 가부시키가이샤 아네로파마·사이엔스 Ischemic disease therapeutic agent
US9252578B2 (en) 2013-03-15 2016-02-02 Hubbell Incorporated Cable connector and electrical box assembly
CA2936053A1 (en) * 2014-01-10 2015-07-16 Teikyo Heisei University Recombinant obligate anaerobic gram-positive bacteria
WO2015120541A1 (en) 2014-02-14 2015-08-20 Symvivo Corporation Nucleic acid vectors and uses thereof
US10443061B2 (en) 2014-05-01 2019-10-15 Anaeropharma Science, Inc. Heterologous polypeptide expression cassette
CA2947529C (en) * 2014-05-02 2022-06-21 Shinshu University Antibody gene expression-secretion system
EP3228706B1 (en) * 2014-12-03 2021-06-23 Azusapharma Sciences, Inc. Coexpression plasmid
CA2974333C (en) 2015-01-19 2018-09-25 Shinshu University Therapeutic agent for ischemic disease
CN110448681B (en) * 2019-08-26 2020-12-15 君维安(武汉)生命科技有限公司 Combined medicine for malignant tumor immunotherapy
EP4023245A4 (en) 2019-08-28 2023-08-30 Azusapharma Sciences, Inc. Bifidobacterium spp. expressing and secreting diabody-type bsab

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416754B1 (en) 1994-03-03 2002-07-09 The Board Of Trustees Of The Leland Stanford Junior University Anaerobe targeted enzyme-mediated prodrug therapy
US6984513B2 (en) * 1994-03-03 2006-01-10 The Board Of Trustees Of The Leland Stanford Junior University Anaerobe targeted enzyme-mediated prodrug therapy
JP3642755B2 (en) 2000-09-21 2005-04-27 純 天野 Drugs for gene therapy using anaerobic bacteria
CA2342040C (en) * 2000-09-21 2012-07-10 Kyowa Hakko Kogyo Co., Ltd. Anaerobic bacterium as a drug for cancer gene therapy
CA2432797C (en) 2000-12-18 2014-02-04 David J. Yang Local regional chemotherapy and radiotherapy using in situ hydrogel
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
KR100457879B1 (en) 2001-02-24 2004-11-18 주식회사 비피도 Plasmid originated from Bifidobacterium, recombinant expression vector using the plasmid and transformation method
KR20110097841A (en) 2001-12-31 2011-08-31 안티캔서, 인코포레이티드 System for monitoring bacterial tumor treatment
EP1682572A4 (en) * 2003-10-24 2009-01-28 Univ Queensland Protein expression
EP1655370A1 (en) 2004-11-05 2006-05-10 Gesellschaft für Biotechnologische Forschung Bacterial vector
EP1829963A4 (en) 2004-11-24 2009-01-28 Anaeropharma Science Inc Novel shuttle vector
KR100967868B1 (en) 2004-12-17 2010-07-05 베쓰 이스라엘 디코니스 메디칼 센터 Compositions for bacterial mediated gene silencing and methods of using same
CA2646244A1 (en) 2006-03-27 2007-10-04 Government Of The United States Of Americas, As Represented By The Secre Tetracycline compounds and methods of treatment
AU2007238228A1 (en) 2006-04-13 2007-10-25 Ambrozea, Inc. Compositions and methods for producing fermentation products and residuals
JP5048661B2 (en) * 2006-05-24 2012-10-17 株式会社アネロファーマ・サイエンス Gene transport carrier production method
CN1974759B (en) 2006-07-26 2010-06-09 吉林大学 Attenuated salmonella transporting recombinant plasmid and its application in treating tumor
ES2628378T3 (en) 2008-04-17 2017-08-02 Anaeropharma Science, Inc. Plasmid vector
US20130095072A1 (en) 2010-01-29 2013-04-18 Anaeropharma Science, Inc. Therapeutic agent for ischemic diseases
JPWO2010126073A1 (en) 2009-04-28 2012-11-01 協和発酵キリン株式会社 Expression cassette for the secretory expression of polypeptides and uses thereof
EP2910636B1 (en) 2010-01-29 2018-01-17 Anaeropharma Science, Inc. Transformation plasmid

Also Published As

Publication number Publication date
WO2011093468A1 (en) 2011-08-04
JPWO2011093467A1 (en) 2013-06-06
JPWO2011093465A1 (en) 2013-06-06
US20110189757A1 (en) 2011-08-04
KR20120112824A (en) 2012-10-11
EP2910636A3 (en) 2015-12-02
CA2787590A1 (en) 2011-08-04
CN102741407B (en) 2014-12-10
US9228191B2 (en) 2016-01-05
US20110189758A1 (en) 2011-08-04
CN102741407A (en) 2012-10-17
JP5836129B2 (en) 2015-12-24
EP2530151A4 (en) 2013-10-23
EP2530150A4 (en) 2013-10-23
CN102834514B (en) 2015-08-19
JP5841432B2 (en) 2016-01-13
CN102834514A (en) 2012-12-19
EP2896695A2 (en) 2015-07-22
CA2787787A1 (en) 2011-08-04
KR101850162B1 (en) 2018-04-18
US20110190472A1 (en) 2011-08-04
KR20120128638A (en) 2012-11-27
EP2910636B1 (en) 2018-01-17
CA2787590C (en) 2019-01-15
EP2910636A2 (en) 2015-08-26
EP2530150A1 (en) 2012-12-05
WO2011093467A1 (en) 2011-08-04
US8535939B2 (en) 2013-09-17
SG182446A1 (en) 2012-08-30
EP2896695A3 (en) 2015-09-23
EP2530151A1 (en) 2012-12-05
WO2011093465A1 (en) 2011-08-04
SG182445A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2566479A4 (en) Azaindazoles
EP2640189A4 (en) 3-deutero-pomalidomide
SG10201500719VA (en) Transformation plasmid
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2651505A4 (en) Electroporation-induced electrosensitization
HK1183325A1 (en) Self-deleting plasmid
EP2641891A4 (en) Pkc- activator
IL224507A (en) Next-instruction-type field
GB2481646B (en) Agrictultural implement
GB201001385D0 (en) Cable-tidies
GB201007450D0 (en) Transformation
TWI366500B (en) Tongs
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
GB201010836D0 (en) Easy squeezy
GB201118780D0 (en) Energy-liberating transformation
GB201006710D0 (en) Cart
GB201015314D0 (en) Improved fly-hook
AU2010278V (en) Little Tuffy Lomandra confertifolia
AU2010194V (en) CalpenGL Calothamnus quadrifidus